Abstract:Thrombocytopenia is a common finding in small for gestational age (SGA) neonates and is thought to result from a unique pathophysiologic mechanism related to chronic intrauterine hypoxia. Our objective was to estimate the incidence and severity of early-onset thrombocytopenia in SGA neonates, and to identify risk factors for thrombocytopenia. We performed a retrospective cohort study of all consecutive SGA neonates admitted to our ward and a control group of appropriate for gestational age (AGA) neonates match… Show more
“…Such thrombocytopenia is commonly seen in SGA infants, 1,3,4,12 with even evidence for a (linear) relation between platelet counts and birth weight centile. 4,13 Typically, thrombocytopenia onset in SGA infants is early (<72 hours after birth), only a minority of patients (5%) require platelet transfusion, and no infants are yet reported with a platelet count <20 × 10 9 /L. 13 Additional risk factors for thrombocytopenia were present in our patient, such as maternal diabetes and pre-eclampsia, which causes neonatal platelet depletion in up to 30%.…”
Section: Discussionmentioning
confidence: 78%
“…4,13 Typically, thrombocytopenia onset in SGA infants is early (<72 hours after birth), only a minority of patients (5%) require platelet transfusion, and no infants are yet reported with a platelet count <20 × 10 9 /L. 13 Additional risk factors for thrombocytopenia were present in our patient, such as maternal diabetes and pre-eclampsia, which causes neonatal platelet depletion in up to 30%. 14 As was expected, the initial platelet depletion in our patient resolved spontaneously, and platelet count was found to be normal at 72 hours of life.…”
Thrombocytopenia (platelet count <150 × 109/L) regularly occurs in newborns but is especially observed in critically ill neonates. We describe the case of a small for gestational age (SGA) neonate, who showed an unexpected, severe thrombocytopenia (8 × 109/L) at day 5 of life. The thrombocytopenia recovered completely after cessation of ranitidine (0.5 mg/kg/6 hr), which was started in a context of feeding difficulties. Other causes of neonatal thrombocytopenia were ruled out. Besides a brief report on a cimetidine-induced thrombocytopenia over 25 years ago, no other neonatal or pediatric cases of H2 antagonist-induced thrombocytopenia have been reported to date, although being widely used in routine care. Moreover, several adult cases have been published. In general, neonatal thrombocytopenia, although one of the most frequent hematological conditions in newborns, is only rarely attributed to an adverse drug reaction. Clinicians should be aware of the risks for adverse reactions, especially in routinely used drugs and in critically ill patients.
“…Such thrombocytopenia is commonly seen in SGA infants, 1,3,4,12 with even evidence for a (linear) relation between platelet counts and birth weight centile. 4,13 Typically, thrombocytopenia onset in SGA infants is early (<72 hours after birth), only a minority of patients (5%) require platelet transfusion, and no infants are yet reported with a platelet count <20 × 10 9 /L. 13 Additional risk factors for thrombocytopenia were present in our patient, such as maternal diabetes and pre-eclampsia, which causes neonatal platelet depletion in up to 30%.…”
Section: Discussionmentioning
confidence: 78%
“…4,13 Typically, thrombocytopenia onset in SGA infants is early (<72 hours after birth), only a minority of patients (5%) require platelet transfusion, and no infants are yet reported with a platelet count <20 × 10 9 /L. 13 Additional risk factors for thrombocytopenia were present in our patient, such as maternal diabetes and pre-eclampsia, which causes neonatal platelet depletion in up to 30%. 14 As was expected, the initial platelet depletion in our patient resolved spontaneously, and platelet count was found to be normal at 72 hours of life.…”
Thrombocytopenia (platelet count <150 × 109/L) regularly occurs in newborns but is especially observed in critically ill neonates. We describe the case of a small for gestational age (SGA) neonate, who showed an unexpected, severe thrombocytopenia (8 × 109/L) at day 5 of life. The thrombocytopenia recovered completely after cessation of ranitidine (0.5 mg/kg/6 hr), which was started in a context of feeding difficulties. Other causes of neonatal thrombocytopenia were ruled out. Besides a brief report on a cimetidine-induced thrombocytopenia over 25 years ago, no other neonatal or pediatric cases of H2 antagonist-induced thrombocytopenia have been reported to date, although being widely used in routine care. Moreover, several adult cases have been published. In general, neonatal thrombocytopenia, although one of the most frequent hematological conditions in newborns, is only rarely attributed to an adverse drug reaction. Clinicians should be aware of the risks for adverse reactions, especially in routinely used drugs and in critically ill patients.
“…SGA infants are defined as having a birth weight of less than the 10th percentile of the population‐specific birth weight for a given gestational age 4 . There have been some reports that SGA infants often have transient thrombocytopenia within the first three days of life 5–7 due to low concentrations of serum thrombopoietin (Tpo) 8,9 . However, the detailed mechanism of thrombocytopenia in SGA infants remains unclear.…”
“…Term SGA newborns showed lower PLT and PCT than non-SGA infants, as previously reported. [17][18][19] Reduced platelet count indicates the immaturity of platelet production in SGA newborns. [20] Thrombopoietin, the main regulator of platelet production, is produced by liver.…”
This study aimed to compare platelet indices between late preterm and term newborns, and to analyze their relationship with perinatal conditions. Material and Method: Ninety-eight late preterm and 102 term newborns admitted to the neonatal intensive care unit between 2018 and 2020 were retrospectively evaluated. Platelet indices including platelet count (PLT), mean platelet volume (MPV), plateletcrit (PCT), and platelet distribution width (PDW) were measured in blood samples taken on the first day of life. Results: There was no significant difference in the PLT, MPV, PCT, and PDW values between late preterm and term newborns. In late preterm newborns, multivariable analysis showed that maternal hypertension was significantly related to lower PLT (p=0.001). In term newborns, multivariable analysis showed that being small for gestational age (SGA), male sex, and maternal hypertension were significantly related to lower PLT (p<0.001, p=0.001 and p=0.017, respectively). In addition, SGA and male sex were related to lower PCT (p=0.001). In all studied patients, MPV was significantly different between infants with and without prolonged rupture of membrane (PROM) (9.8 fL vs. 9.2 fL, p=0.001).
Conclusion:The obtained results show that various perinatal features influence the platelet indices in late preterm and term newborns.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.